摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Benzyloctahydro-2H-pyrido<1,2-a>pyrazin-7-one | 134334-40-0

中文名称
——
中文别名
——
英文名称
2-Benzyloctahydro-2H-pyrido<1,2-a>pyrazin-7-one
英文别名
2-Benzylhexahydro-2H-pyrido[1,2-a]pyrazin-7(6H)-one;2-benzyl-3,4,6,8,9,9a-hexahydro-1H-pyrido[1,2-a]pyrazin-7-one
2-Benzyloctahydro-2H-pyrido<1,2-a>pyrazin-7-one化学式
CAS
134334-40-0
化学式
C15H20N2O
mdl
——
分子量
244.337
InChiKey
JRDZNVYAXWHPTO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    23.6
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • The Synthesis of 2,7-Substituted Octahydro-2H-Pyrido[1,2-a] Pyrazines, Analogues of Quinolizidine and Piperazine Drugs
    作者:M.Ashty Saleh、Frans Compernolle、Suzanne Toppet、Georges J. Hoornaert
    DOI:10.1016/s0040-4020(01)80853-x
    日期:1994.1
    versatility of amino ketone 2 (2-benzyloctahydro-2H-pyrido[1,2-a]pyrazin-7-one) was demonstrated by the synthesis of 2,7-substituted derivatives, designed as analogues of both quinolizidine and piperazine drugs. The 7- ketone group was functionalized via Grignard reaction with o- and p-fluorophenylmagnesium bromide, followed by dehydration and hydrogenation. Final substitution of the 2-amino group
    基酮2(2-苄基八氢-2H-吡啶并[1,2-a]吡嗪-7-酮)的多功能性通过合成2,7-取代的衍生物得到证明,该衍生物被设计为喹喔啉哌嗪药物的类似物。通过与邻和对苯基溴化镁的格氏反应,将7-酮基官能化,然后进行脱和氢化。2-基的最终取代得到2-吡啶基和对氟苯甲酰基目标化合物10和11。
  • Synthesis of 2,5-substituted piperidines and their bicyclic piperazine analogs: the 2,7-substituted octahydro-2H-pyrido[1,2-a]pyrazines
    作者:Frans Compernolle、M. Ashty Saleh、Suzanne Toppet、Georges Hoornaert
    DOI:10.1021/jo00017a036
    日期:1991.8
    Partial and complete reduction of the key compound 1-benzyl-5-(ethylenedioxy)-2-piperidinecarbonitrile (1) was applied to generate the corresponding aldehyde 2 and primary amine 3. These were transformed into bicyclic 7-(ethylenedioxy)-2(R)-octahydro-2H-pyrido[1,2-a]pyrazines 7 (R = H) and 15 (R = aryl) through the following sequence: (i) chloroacetylation of 3 and of arylamines derived from 2, (ii) cyclization to give the intermediate lactams 5 and 14, and (iii) reduction with LiAlH4. Deprotection of the N-aryl compounds 15 yielded the corresponding ketone model compounds 16. From amino acetal 7, a complementary ketone synthon 11 was prepared via N-benzylation and cleavage of the acetal group, providing a general route to piperidine-bridged analogues of 1,4-substituted piperazine drugs.
  • Saleh M. Ashty, Compernolle Frans, Toppet Suzanne, Hoornaert Georges J., Tetrahedron, 50 (1994) N 6, S 1811-1820
    作者:Saleh M. Ashty, Compernolle Frans, Toppet Suzanne, Hoornaert Georges J.
    DOI:——
    日期:——
查看更多

同类化合物

麦可弗汀A 罗哌卡因杂质 六氢-2-甲基-2H-吡啶并[1,2-a]吡嗪-1,6-二酮 八氢吡啶并〔1,2-A〕吡嗪-6-酮 八氢吡啶并[1,2-a]吡嗪 八氢-吡啶并[1,2-A]吡嗪-4-酮盐酸盐 八氢-6H-吡啶并[1,2-a]吡嗪-6-酮盐酸盐 八氢-3-甲基-2H-吡啶并[1,2-a]吡嗪 八氢-2H-吡啶并[1,2-a]吡嗪二盐酸盐 八氢-2H-吡啶并[1,2-a]吡嗪-6-甲醇 7-甲氧基辛a氢-2H-吡啶并[1,2-a]吡嗪-2-胺 7-乙基八氢-2H-吡啶并[1,2-a]吡嗪-2-胺 6-甲基八氢-2H-吡啶并[1,2-a]吡嗪-2-胺 4H-吡唑[1,2-A]吡嗪-4-八氢酮 3-甲基八氢-2H-吡啶并[1,2-a]吡嗪-2-胺 2-苄基八氢-1H-吡啶并[1,2-a]吡嗪 2-硝基八氢-2H-吡啶并[1,2-a]吡嗪 2-乙基六氢-2H-吡啶并[1,2-a]吡嗪-1(6H)-酮 2-(9-甲基-3,9-二氮杂双环[3.3.1]壬-3-基)乙胺 2-(4-甲硫基唑-5-基)乙基丁酸酯 2,3,4,6,7,8,9,9alpha-八氢-1H-吡啶并[1,2-a]吡嗪-3-基甲醇 1,1'-联苯基,2-乙基-5-甲氧基- (R)-八氢吡啶并[1,2-A〕吡嗪二盐酸盐 (9aS)-八氢-4H-吡啶并[1,2-a]吡嗪-4-酮 (9aR)-八氢-2H-吡啶并[1,2-a]吡嗪 (9SS)-八氢-2-吡啶-吡嗪盐酸盐[1,2-A] (7r,9as)-八氢-2H-吡啶并[1,2-a]吡嗪-7-甲醇 (3S,6S)-3-苄基-1,4-二氮杂双环[4.4.0]癸烷-2,5-二酮 ((7S,9as)-八氢-1H-吡啶并[1,2-a]吡嗪-7-基)甲醇 ((6R,9as)-八氢-1H-吡啶并[1,2-a]吡嗪-6-基)甲醇 cyclo-(D-Leu-D-Pip) (3S,9aR)-hexahydro-3-methyl-6H-pyrido[1,2-a]pyrazine-1,4-dione (9aS)-2-benzyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine 3-[3-(1,3,4,6,7,8,9,9a-Octahydropyrido[1,2-a]pyrazine-2-carbonyl)-2-methoxyanilino]-4-(2-chloro-3-fluoroanilino)cyclobut-3-ene-1,2-dione (7R,9aS)-trans-7-(3-morpholin-4-ylmethylphenoxymethyl)-octahydro-pyrido[1,2-a]pyrazine-2-carboxylic acid tert-butyl ester 3-[3-(1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine-2-carbonyl)-2-methoxyanilino]-4-[[(1R)-1-phenylpropyl]amino]cyclobut-3-ene-1,2-dione 3-Chinolizidin-1-yl-2-methylindol 2-propyl-octahydro-pyrido[1,2-c][1,3,6]oxadiazocine (8R,9aS)-2-benzyl-3,3-dioxido-1-oxooctahydropyrrolo[2,1-d][1,2,5]thiadiazepin-8-yl cyclohexylcarbamate 2-(5-Amino-2-methoxy-phenyl)-hexahydro-pyrido[1,2-a]pyrazin-3-one 14α-hydroxy-15α-methyl-16β-methylsulfinyl-17-oxomarcfortine A (1S,7S,10S)-12-Acetyl-9-thia-3,12-diaza-tricyclo[8.2.1.03,7]tridecan-2-one (4-Aminophenyl)-(1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-2-yl)methanone 3-Benzylaminomethyl-chinolizidin rac-(4aR,8aR)-1-(piperidin-3-yl)-decahydroquinoline (1S,7R,10S)-12-Acetyl-9-thia-3,12-diaza-tricyclo[8.2.1.03,7]tridecan-2-one N-((1R,2S,5R)-2-((S)-3-amino-2-oxopyrrolidin-1-yl)-5-(isopropylamino)cyclohexyl)acetamide 2-tert-butylperhydroimidazolo<3,4-a>pyridine 1,3,4,6,7,8,9,9a-Octahydropyrido[1,2-a]pyrazin-2-yl-(2-chloro-5-phenylthiophen-3-yl)methanone 3-[2-oxo-2-[5-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-5,9-diazaspiro[2.6]nonan-9-yl]ethyl]thiazolidine-2,4-dione